The presence of cleaved PARP1 and cleaved Caspase 3 demonstrated the activation of the apoptotic pathways in CML cells treated with the DHODH inhibitor (Fig. 1D). The gene discussed is PARP1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.